BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29423349)

  • 1. Complex versus simple models: ion-channel cardiac toxicity prediction.
    Mistry HB
    PeerJ; 2018; 6():e4352. PubMed ID: 29423349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessment.
    Mistry HB; Davies MR; Di Veroli GY
    Front Pharmacol; 2015; 6():59. PubMed ID: 25852560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Bnet, a Simple Linear Metric in Discerning Torsades De Pointes Risks in 28 CiPA Drugs.
    Han S; Han S; Kim KS; Lee HA; Yim DS
    Front Pharmacol; 2019; 10():1419. PubMed ID: 31849669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real Patient and its Virtual Twin: Application of Quantitative Systems Toxicology Modelling in the Cardiac Safety Assessment of Citalopram.
    Patel N; Wiśniowska B; Jamei M; Polak S
    AAPS J; 2017 Nov; 20(1):6. PubMed ID: 29181593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an in silico cardiac safety assay: using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.
    Beattie KA; Luscombe C; Williams G; Munoz-Muriedas J; Gavaghan DJ; Cui Y; Mirams GR
    J Pharmacol Toxicol Methods; 2013; 68(1):88-96. PubMed ID: 23624022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment.
    Elkins RC; Davies MR; Brough SJ; Gavaghan DJ; Cui Y; Abi-Gerges N; Mirams GR
    J Pharmacol Toxicol Methods; 2013; 68(1):112-22. PubMed ID: 23651875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel-Drug Binding Kinetics and Multichannel Pharmacology.
    Li Z; Dutta S; Sheng J; Tran PN; Wu W; Chang K; Mdluli T; Strauss DG; Colatsky T
    Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):e004628. PubMed ID: 28202629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative.
    Li Z; Ridder BJ; Han X; Wu WW; Sheng J; Tran PN; Wu M; Randolph A; Johnstone RH; Mirams GR; Kuryshev Y; Kramer J; Wu C; Crumb WJ; Strauss DG
    Clin Pharmacol Ther; 2019 Feb; 105(2):466-475. PubMed ID: 30151907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [hiPSCs and organoids: prediction of arrhythmogenic risks for optimized traditional Chinese medicine].
    Sun HK; Gao Y; Zhu MJ; Tang JF; Wu Y; Li B; Yu R; Wang Y; Zhou LY
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5404-5409. PubMed ID: 38114134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CiPA: Ongoing testing, future qualification procedures, and pending issues.
    Cavero I; Holzgrefe H
    J Pharmacol Toxicol Methods; 2015; 76():27-37. PubMed ID: 26159293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute coronary event (ACE) prediction following breast radiotherapy by features extracted from 3D CT, dose, and cardiac structures.
    Choi BS; Yoo SK; Moon J; Chung SY; Oh J; Baek S; Kim Y; Chang JS; Kim H; Kim JS
    Med Phys; 2023 Oct; 50(10):6409-6420. PubMed ID: 36974390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proarrhythmia liability assessment and the comprehensive in vitro Proarrhythmia Assay (CiPA): An industry survey on current practice.
    Authier S; Pugsley MK; Koerner JE; Fermini B; Redfern WS; Valentin JP; Vargas HM; Leishman DJ; Correll K; Curtis MJ
    J Pharmacol Toxicol Methods; 2017 Jul; 86():34-43. PubMed ID: 28223123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CiPA challenges and opportunities from a non-clinical, clinical and regulatory perspectives. An overview of the safety pharmacology scientific discussion.
    Wallis R; Benson C; Darpo B; Gintant G; Kanda Y; Prasad K; Strauss DG; Valentin JP
    J Pharmacol Toxicol Methods; 2018; 93():15-25. PubMed ID: 29958940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considering population variability of electrophysiological models improves the in silico assessment of drug-induced torsadogenic risk.
    Llopis-Lorente J; Trenor B; Saiz J
    Comput Methods Programs Biomed; 2022 Jun; 221():106934. PubMed ID: 35687995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliable identification of cardiac liability in drug discovery using automated patch clamp: Benchmarking best practices and calibration standards for improved proarrhythmic assessment.
    Brinkwirth N; Takasuna K; Doi M; Becker N; Obergrussberger A; Friis S; Furukawa H; Hasegawa Y; Oka T; Ohtsuki A; Fertig N; Stoelzle-Feix S
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106884. PubMed ID: 32565325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative.
    Huang H; Pugsley MK; Fermini B; Curtis MJ; Koerner J; Accardi M; Authier S
    J Pharmacol Toxicol Methods; 2017 Sep; 87():11-23. PubMed ID: 28408211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysics and Molecular Biology of Cardiac Ion Channels for the Safety Pharmacologist.
    Pugsley MK; Curtis MJ; Hayes ES
    Handb Exp Pharmacol; 2015; 229():149-203. PubMed ID: 26091640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.